FDA Withdraws Rule Proposing Public Disclosure of IND Data from Gene Therapies

Drug Industry Daily
The FDA withdrew a rule proposed in 2001 that would have required the public disclosure of certain data related to unapproved human gene therapy or the transplantation of non-human tissues to humans from companies seeking approval of investigational new drugs.

To View This Article:


Subscribe To Drug Industry Daily